MRCS syndrome

MRCS syndrome (Microcornea, Rod-Cone dystrophy, Cataract, and posterior Staphyloma syndrome) is an extremely rare inherited eye disorder characterized by a distinctive combination of ocular abnormalities. The acronym MRCS reflects its four cardinal features: microcornea (an abnormally small cornea), rod-cone dystrophy (a progressive degeneration of the photoreceptor cells in the retina leading to vision loss), cataract (clouding of the lens), and posterior staphyloma (an outward bulging of the back wall of the eye). These features collectively lead to significant visual impairment that typically progresses over time. The condition primarily affects the eye, involving both the anterior segment (cornea and lens) and the posterior segment (retina and sclera). Rod-cone dystrophy causes progressive loss of night vision followed by deterioration of peripheral and eventually central vision. The posterior staphyloma can contribute to axial myopia (nearsightedness) and further visual compromise. Cataracts may develop early and compound the visual difficulties caused by the retinal dystrophy. There is currently no curative treatment for MRCS syndrome. Management is supportive and symptomatic, focusing on optimizing remaining vision. Cataract surgery may be considered when lens opacities significantly impair vision, though outcomes may be limited by the concurrent retinal dystrophy. Regular ophthalmological monitoring is important to track disease progression. Low-vision aids and rehabilitation services can help affected individuals maximize their functional vision. Genetic counseling is recommended for affected families.

Common questions about MRCS syndrome